Gyre Therapeutics (GYRE) Operating Leases (2019 - 2026)
Gyre Therapeutics' Operating Leases was $2.03 million in Q2 2026, up 163.7% from $771,000 a year earlier.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Gyre Therapeutics came in at $2.3 million, up 160.2% from FY2024.
- Operating Leases has now increased for three consecutive years, with a five-year compound annual growth rate of 18.6% (FY2020 to FY2025).
- In earlier years, Operating Leases was $885,000 in FY2024 (+344.7%), $199,000 in FY2023 (+64.5%), $121,000 in FY2022 (-70.3%) and $408,000 in FY2021 (-58.4%).
- Quarterly Operating Leases has moved between $72,000 (Q1 2026) and $2.3 million (Q4 2025) over five years.
- Compared with a year earlier, Operating Leases was higher in four of the last seven quarters, with growth averaging 118.9%.
- The best year-over-year quarter for Operating Leases over five years was Q1 2025 (growth of 345.7%); the worst was Q1 2026 (a decline of 90.8%).
- Per Business Quant data, GYRE's Operating Leases in the three quarters before Q2 2026 was $72,000 (Q1 2026), $2.3 million (Q4 2025) and $539,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Gyre Therapeutics | 487.81 Mn | 295.13 Mn | 30.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.87 Mn |
| Jun 30, 2026 | 2.03 Mn |
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | 2.30 Mn |
| Sep 30, 2025 | 539,000.00 |
| Jun 30, 2025 | 771,000.00 |
| Mar 31, 2025 | 780,000.00 |
| Dec 31, 2024 | 885,000.00 |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 175,000.00 |
| Dec 31, 2023 | 199,000.00 |
| Dec 31, 2022 | 121,000.00 |
| Sep 30, 2022 | 381,000.00 |
| Jun 30, 2022 | 1.42 Mn |
| Mar 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | 408,000.00 |
| Sep 30, 2021 | 550,000.00 |
| Jun 30, 2021 | 1.05 Mn |
| Mar 31, 2021 | 806,000.00 |
API Access
Gyre Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();